A protein already targeted by FDA-approved cancer drugs may also help the body fight influenza, according to new research from The Jackson Laboratory (JAX). Published in Cell Reports, the study found ...
A newly discovered cancer trick that weakens immunotherapy may be stopped by everyday statins.
The following is an English translation of an article originally published in Spanish in Salud con Lupa. Para leer este artículo en español, haga clic aquí. Peru's Ministry of Health ...
NEW YORK, Feb 23 (Reuters) - Bayer (BAYGn.DE), opens new tab sued Johnson & Johnson (JNJ.N), opens new tab on Monday, accusing the drugmaker of falsely advertising that its rival multibillion-dollar ...
Bayer BAYGn.DE sued Johnson & Johnson JNJ.N on Monday, accusing the drugmaker of falsely advertising a rival multibillion-dollar drug to treat prostate cancer. In a complaint filed in Manhattan ...
Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...
The pharmaceutical giant is finding ways to navigate despite headwinds. This has helped the shares outperform the market over the past year. Income investors should be pleased with Merck's dividend ...
As Candel Therapeutics gears up for a planned U.S. approval push for its prostate cancer drug later this year, RTW Investments has stepped in with $100 million to bankroll the launch. The nine-figure ...
Pancreatic cancer accounts for a disproportionate number of cancer-related deaths relative to its incidence, reflecting its aggressive biology and limited treatment options. Most cases are exocrine ...
Some six years after the FDA approved Eli Lilly’s Retevmo to treat lung and thyroid cancers that have a mutation or fusion to the RET gene, the Indianapolis drugmaker is laying groundwork to move the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results